Gostanian Richard 5

Accession 0001736069-18-000013

CIK 0001559356other

View on SEC.gov Company Profile

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 9:08 PM ET

Size

34.2 KB

Accession

0001736069-18-000013

Insider Transaction Report

Form 5

Period: 2017-12-31

Immune Therapeutics, Inc.imun

Gostanian Richard

Other

Transactions

Purchase
common
2017-12-04$0.02/sh+15,000$282→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-08$0.02/sh+6,300$106→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-11$0.01/sh+15,000$225→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-13$0.01/sh+50,000$600→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-13$0.01/sh+15,000$207→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-07$0.02/sh+15,000$235→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-08$0.02/sh+20,000$312→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-08$0.01/sh+15,000$210→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-11$0.01/sh+15,000$209→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-27$0.02/sh+20,000$458→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-28$0.02/sh+30,000$600→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-07$0.02/sh+10,000$156→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-08$0.02/sh+2,450$41→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-27$0.02/sh+10,000$180→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-08$0.02/sh+1,250$20→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-01$0.02/sh+10,000$198→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-04$0.02/sh+20,000$340→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-06$0.01/sh+20,000$278→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)
Purchase
common
2017-12-27$0.02/sh+10,000$225→ 12,949,027 total(indirect: richard gostanian & kathryn veselic joint account at etrade)

Documents

1 file

5
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Immune Therapeutics, Inc.

CIK 0001559356

→

Entity typeother

Related Parties

filerCIK 0001736069

Filing Metadata

Form type: 5
Filed: Apr 1, 8:00 PM ET
Accepted: Apr 2, 9:08 PM ET
Size: 34.2 KB

View on SEC.gov